Nxstage Medical's Home Dialysis System Gets FDA Go-Ahead - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 24, 11:50AM CST
Nxstage Medical, Inc.'s (NXTM) System One is cleared by the FDA to perform hemodialysis overnight while the patient is at home, making it the first and only hemodialysis machine cleared for this indication.
ICUI: 83.38 (+1.63), NXTM: 18.39 (+0.33), BAX: 74.45 (-0.04), FMS: 37.40 (+0.15)
Baxter Seeks FDA Approval of BAX111 to Advance VWD Cure - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 3:00PM CST
Baxter International Inc. (BAX) filed a BLA with the FDA for the approval of BAX 111 - an investigational drug for the treatment of patients with von Willebrand disease (VWD).
ICUI: 83.38 (+1.63), BAX: 74.45 (-0.04), NKTR: 15.02 (+0.23), OSUR: 10.26 (+0.25)
Strength Seen in Cardica (CRDC): Stock Rises 5.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 23, 8:25AM CST
Cardica (CRDC) was a big mover last session, with shares rising nearly 9% on the day.
ICUI: 83.38 (+1.63), CRDC: 0.69 (unch)
InsiderInsights.com Daily Round Up 12/22/14: LTS, GLP, WIA, GDLPRB
InsiderInsights - at Seeking Alpha - Tue Dec 23, 2:38AM CST
DEI: 28.75 (-0.13), SLG: 120.98 (-0.95), RMP: 15.88 (+0.14), ASPX: 49.93 (-0.10), HCCI: 11.76 (-0.41), MLNK: 3.69 (-0.01), LTS: 4.10 (+0.07), ADBE: 74.74 (+0.36), FDS: 144.52 (+0.15), K: 67.02 (-0.22), ICUI: 83.38 (+1.63), BH: 373.44 (-1.69), WIW: 11.28 (+0.03), GLP: 34.90 (-0.19), SNCR: 43.24 (+0.21), WDAY: 84.28 (-0.58), ALCO: 49.88 (-0.50), WIA: 11.55 (+0.06)
Neogen Q2 Earnings & Revenues Lag Estimates, Rise Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 22, 8:00AM CST
Since the earnings announcement, shares of Neogen Corp. (NEOG) rose about 1.2% to close at $48.28 in the last trading session.
ICUI: 83.38 (+1.63), ABAX: 58.48 (+0.22), NEOG: 48.21 (-0.10), OSUR: 10.26 (+0.25)
34.7% Return Seen to Date on SmarTrend ICU Medical Call (ICUI)
Comtex SmarTrend(R) - Fri Dec 19, 4:55PM CST
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 4 months, ICU Medical has returned 34.68% as of today's recent price of $83.77.
ICUI: 83.38 (+1.63)
Smith & Nephew Up on Post-Operative Wound Therapy Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 19, 3:26PM CST
Smith & Nephew's (SNN) PICO Single Use NPWT is a revolutionary canister-free system that has been designed to promote optimal wound healing.
ICUI: 83.38 (+1.63), SNN: 38.18 (+0.14), ABAX: 58.48 (+0.22), OSUR: 10.26 (+0.25)
Strength Seen in Cerus (CERS): Stock Soars 22.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 18, 8:25AM CST
Cerus (CERS) was a big mover last session, with shares rising roughly 23% on the day.
CERS: 6.49 (+0.29), ICUI: 83.38 (+1.63)
Baxter to Vend Vero Cell Vaccine Platform to Nanotherapeutics - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 5:10PM CST
Baxter International Inc (BAX) is set to divest its Vero cell technology and related assets to Nanotherapeutics, Inc for an undisclosed amount
ICUI: 83.38 (+1.63), BAX: 74.45 (-0.04), PFE: 31.42 (-0.03), OSUR: 10.26 (+0.25)
PerkinElmer (PKI) Closes Acquisition of Perten Instruments - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 3:00PM CST
The completion of the acquisition is not expected to have a material impact on PerkinElmer Inc.'s (PKI) results for the fourth quarter of 2014.
ICUI: 83.38 (+1.63), ABAX: 58.48 (+0.22), PKI: 43.99 (-0.06), OSUR: 10.26 (+0.25)
Boston Scientific's Chronic Pain Cure Solution Tests Positive - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 2:40PM CST
The study results are indicative of the fact that Boston Scientific's (BSX) next-generation Precision Spectra SCS System can offer sustainable respite for patients suffering from chronic low back pain.
BSX: 13.13 (+0.07), ICUI: 83.38 (+1.63), ABAX: 58.48 (+0.22), OSUR: 10.26 (+0.25)
Medtronic (MDT) Launches 2 CRT Quadripolar Leads in US - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 15, 1:20PM CST
Medtronic's (MDT) new leads can be implanted in patients with varying vessel sizes and curvatures, to facilitate better pumping efficiency of the heart in a wide range of heart failure patients.
ICUI: 83.38 (+1.63), MDT: 74.08 (+0.31), ABAX: 58.48 (+0.22), OSUR: 10.26 (+0.25)
Will Medtronic's Endurant AAA Stent Graft Last Long? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 1:40PM CST
Medtronic's (MDT) Endurant AAA stent graft system ??? a global leader in the coronary & structural heart device category ??? is compatible with a broad range of aortic anatomies.
ICUI: 83.38 (+1.63), MDT: 74.08 (+0.31), ABAX: 58.48 (+0.22), OSUR: 10.26 (+0.25)
St. Jude Medical's Quadra Allure Pacemaker Gets CE Mark - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 11:30AM CST
The Quadra Allure MP CRT-P expands St. Jude Medical Inc.'s (STJ) heart failure portfolio which includes the CardioMEMS HF Monitoring System, implantable cardioverter defibrillators, quadripolar and multi-point pacing systems.
ICUI: 83.38 (+1.63), ABAX: 58.48 (+0.22), STJ: 66.67 (+0.67), OSUR: 10.26 (+0.25)
ICU Medical Has Returned 30.3% Since SmarTrend Recommendation (ICUI)
Comtex SmarTrend(R) - Fri Dec 12, 11:16AM CST
SmarTrend identified an Uptrend for ICU Medical (NASDAQ:ICUI) on August 12th, 2014 at $62.20. In approximately 4 months, ICU Medical has returned 30.26% as of today's recent price of $81.02.
ICUI: 83.38 (+1.63)
Agios Pharmaceuticals (AGIO) Looks Good: Stock Up 6.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 8:25AM CST
Agios Pharmaceuticals (AGIO) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 83.38 (+1.63), ABAX: 58.48 (+0.22), AGIO: 109.67 (+2.45), OSUR: 10.26 (+0.25)
TG Therapeutics, Inc. (TGTX) in Focus: Stock Soars 21.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 8:21AM CST
TG Therapeutics, Inc. (TGTX) was a big mover last session, as the company saw its shares rise by over 21% on the day.
ICUI: 83.38 (+1.63), ABAX: 58.48 (+0.22), TGTX: 16.03 (+0.33), OSUR: 10.26 (+0.25)
Baxter Files Form 10 with SEC, Advances Baxalta Spin-off - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 11:40AM CST
In March this year, Baxter International Inc. (BAX) had announced its intention to separate its biopharmaceuticals and medical device segments into two independent companies - Baxter International Inc. and Baxalta Incorporated.
ICUI: 83.38 (+1.63), ABAX: 58.48 (+0.22), BAX: 74.45 (-0.04), OSUR: 10.26 (+0.25)
Alere's HIV Combo Test Gets CLIA Waiver from the FDA - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 11:20AM CST
Shares of Alere Inc. (ALR) rose 1.1% in the trading session after the news on Tuesday but pulled back to close the day lower at $37.86.
ICUI: 83.38 (+1.63), ABAX: 58.48 (+0.22), ALR: 37.48 (+0.37), OSUR: 10.26 (+0.25)
Covidien Loses $176M Award in Patent Case Against JNJ Unit - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 09, 5:45PM CST
The patent infringement war between Covidien plc (COV) and Ethicon Endo-Surgery Inc. received a fresh ruling from the top U.S. patent appeals court last Thursday.
ICUI: 83.38 (+1.63), JNJ: 104.59 (+0.31), GWPH: 68.08 (+1.82), COV: 103.35 (+0.57)